Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase

被引:91
作者
Satpathy, Nbnati
Cao, Liyun
Pincheira, Roxana
Emerson, Robert
Bigsby, Robert
Nakshatri, Harikrishna
Matei, Daniela
机构
[1] Indiana Univ, Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Ctr Canc, Dept Med, Indianapolis, IN 46204 USA
[3] Indiana Univ, Ctr Canc, Dept Pathol & Lab Med, Indianapolis, IN USA
[4] Indiana Univ, Ctr Canc, Dept Obstet & Gynecol, Indianapolis, IN USA
[5] Indiana Univ, Ctr Canc, Dept Surg, Indianapolis, IN USA
[6] Indiana Univ, Ctr Canc, Dept Biochem & Mol Biol, Indianapolis, IN USA
[7] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[8] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
关键词
D O I
10.1158/0008-5472.CAN-07-0307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue transglutaminase (TG2) is involved in Ca2+ -dependent aggregation and polymerization of proteins. We previously reported that TG2 mRNA is up-regulated in epithelial ovarian cancer ((EOC) cells compared with normal ovarian epithelium. Here, we show overexpression of the TG2 protein in ovarian cancer cells and tumors and its secretion in ascites fluid and define its role in EOC. By stable knockdown and overexpression, we show that TG2 enhances EOC cell adhesion to fibronectin and directional cell migration. This phenotype is preserved in vivo, where the pattern of tumor dissemination in the peritoneal space is dependent on TG2 expression levels. TG2 knockdown diminishes dissemination of tumors on the peritoneal surface and mesentery in an i.p. ovarian xenograft model. This phenotype is associated with deficient beta(1) integrin-fibronectin interaction, leading to weaker anchorage of cancer cells to the peritoneal matrix. Highly expressed in ovarian tumors, TG2 facilitates i.p. tumor dissemination by enhancing cell adhesion to the extracellular matrix and modulating, integrin subunit expression.
引用
收藏
页码:7194 / 7202
页数:9
相关论文
共 46 条
[1]   Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade [J].
Ahmed, N ;
Pansino, F ;
Clyde, R ;
Murthi, P ;
Quinn, MA ;
Rice, GE ;
Agrez, MV ;
Mok, S ;
Baker, MS .
CARCINOGENESIS, 2002, 23 (02) :237-244
[2]   Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin [J].
Akimov, SS ;
Krylov, D ;
Fleischman, LF ;
Belkin, AM .
JOURNAL OF CELL BIOLOGY, 2000, 148 (04) :825-838
[3]  
Akimov SS, 2001, J CELL SCI, V114, P2989
[4]   Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells [J].
Antonyak, MA ;
Miller, AM ;
Jansen, JM ;
Boehm, JE ;
Balkman, CE ;
Wakshlag, JJ ;
Page, RL ;
Cerione, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41461-41467
[5]  
Arboleda MJ, 2003, CANCER RES, V63, P196
[6]   E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium [J].
Auersperg, N ;
Pan, J ;
Grove, BD ;
Peterson, T ;
Fisher, J ;
Maines-Bandiera, S ;
Somasiri, A ;
Roskelley, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6249-6254
[7]   Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[8]   Integrin-mediated adhesion and signalling in ovarian cancer cells [J].
Buczek-Thomas, JA ;
Chen, N ;
Hasan, T .
CELLULAR SIGNALLING, 1998, 10 (01) :55-63
[9]   INCREASED LEVELS OF LAMININ IN ASCITIC FLUID OF PATIENTS WITH OVARIAN-CANCER [J].
BYERS, LJ ;
OSBORNE, JL ;
CARSON, LF ;
CARTER, JR ;
HANEY, AF ;
WEINBERG, JB ;
RAMAKRISHNAN, S .
CANCER LETTERS, 1995, 88 (01) :67-72
[10]   EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER [J].
CANNISTRA, SA ;
OTTENSMEIER, C ;
NILOFF, J ;
ORTA, B ;
DICARLO, J .
GYNECOLOGIC ONCOLOGY, 1995, 58 (02) :216-225